Not on air · 2 of 3 networks checked
Lonza Capsugel
- capsugel.com
- Pharmaceutical Manufacturing
- US
- 283 employees
Lonza Capsugel’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 770. Watch Lonza Capsugel with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksNov 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 31 Oct 2026 | See all 770 ads → | ||
| Meta | Not checked | — | |||
| Recently | 200+ | Ads on the Google Ads Transparency Center | Checked 24 Oct 2026 | Collect them with the API → |
Lonza Capsugel has no live LinkedIn ads. We recorded 200+ Google ads on 24 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 2 Oct 2026
Meet Capsugel at CPHI Milan, October 6-8. Find our team at Booth 1A2 in Excipients Hall.
- LINKEDIN · CAROUSELSince 2 Oct 2026
Join us at CPHI 2026 for a series of expert-led sessions covering advanced oral delivery of peptides, nitrosamine risk mitigation, and sustainable supply chain transformation.
- LINKEDIN · VIDEOSince 29 Sept 2026
What if improving patient access started with the dosage form? Oral biologics have the potential to reduce treatment barriers, support patient self-administration, and alleviate pressure on healthcare systems. Explore how Lonza Capsugel is advancing innovative delivery solutions that could help bring complex therapies closer to patients.
- LINKEDIN · VIDEOSince 29 Sept 2026
Advancing oral biologics requires more than overcoming formulation and delivery challenges. Success also depends on identifying solutions that can support commercial manufacturing and product launch. Through integrated capsule and formulation technologies, Lonza Capsugel is helping pharmaceutical innovators develop oral delivery systems designed to meet complex clinical needs while enabling a path toward scalability. Discover how we're supporting the future of oral biologics.
- LINKEDIN · VIDEOSince 29 Sept 2026
Can oral biologics achieve meaningful bioavailability? For many, that remains the defining question. While injectable delivery continues to set the standard, advances in oral formulation technologies are creating new opportunities to improve stability, absorption, and therapeutic performance. Learn how Lonza Capsugel is helping pharmaceutical innovators explore oral delivery strategies for biologics.
- LINKEDIN · VIDEOSince 29 Sept 2026
The future of oral biologics is being shaped by more than science alone. Patient demand for convenient, needle-free therapies is redefining formulation priorities across pharma R&D. See how Lonza Capsugel is helping translate these evolving expectations into innovative oral delivery solutions.
6 of 770 adsSign up to see every Lonza Capsugel ad, filter by format and date, and get alerts on new ones.
See all 770 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.